Evidence map›Paper›PMID 35565410›Full record

ArticleCancers2022

Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma.

Sami Dagher, Abdulrazzaq Sulaiman, Sophie Bayle-Bleuez, Claire Tissot, Valérie Grangeon-Vincent, David Laville, Pierre Fournel, Olivier Tiffet, Fabien Forest

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Prediction of STAS positivity in operable non-small cell lung cancer.Turk gogus kalp damar cerrahisi dergisi · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sami DagherDepartment of Pathology, University Hospital of Saint Etienne, 42055 Saint Etienne, France.
Abdulrazzaq SulaimanDepartment of Thoracic Surgery, University Hospital of Saint Etienne, 42055 Saint Etienne, France.
Sophie Bayle-BleuezDepartment of Pneumology, University Hospital of Saint Etienne, 42055 Saint Etienne, France.
Claire TissotLucien Neuwirth Cancer Institute, 42271 Saint Etienne, France.
Valérie Grangeon-VincentDepartment of Pneumology, Hospital of Roanne, 42300 Roanne, France.
David LavilleDepartment of Pathology, University Hospital of Saint Etienne, 42055 Saint Etienne, France.
Pierre FournelLucien Neuwirth Cancer Institute, 42271 Saint Etienne, France.ORCID 0000-0002-3884-6816
Olivier TiffetDepartment of Thoracic Surgery, University Hospital of Saint Etienne, 42055 Saint Etienne, France.
Fabien ForestDepartment of Pathology, University Hospital of Saint Etienne, 42055 Saint Etienne, France.ORCID 0000-0001-7582-3923
Centre Hospitalier Universitaire de Saint-Étienne · FRInstitute Cancer De La Loire Lucien Neuwirth · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: There is no histoprognostic grading for lung squamous cell carcinoma (LUSC). Different prognostic factors have been described in the recent literature and are not always studied in parallel. Our objective was to search for morphological histopathological prognostic factors in LUSC. Materials and Methods: In this single-center retrospective study of 241 patients, all patients with LUSC who underwent surgical excision over a 12-year period were included. The primary endpoint was 5-year overall survival. Results: STAS was present in 86 (35.7%) patients. The presence of Spread Through Air Spaces (STAS) was correlated with tumor location (p < 0.001), pathological stage (p = 0.039), tumor differentiation (p = 0.029), percentage of necrosis (p = 0.004), presence of vascular and/or lymphatic emboli, budding (p = 0.02), single cell invasion (p = 0.002) and tumor nest size (p = 0.005). The percentage of tumor necrosis was correlated with the overall survival at 5 years: 44.6% of patients were alive when the percentage of necrosis was ≥50%, whereas 68.5% were alive at 5 years when the necrosis was <30% (p < 0.001). When vasculolymphatic emboli were present, the percentage of survival at 5 years was 42.5% compared to 65.5% when they were absent (p = 0.002). The presence of isolated cell invasion was correlated with a lower 5-year survival rate: 51.1% in the case of presence, versus 66% in the case of absence (p = 0.02). In univariate analysis, performance status, pathological stage pT or pN, pleural invasion, histopathological subtype, percentage of tumor necrosis, vasculolymphatic invasion, single-cell invasion, budding and tumor nest size correlated with the percentage of survival at 5 years. On multivariate analysis, only STAS > 3 alveoli (HR, 2.74; 95% CI, 1.18−6.33) was related to overall survival. Conclusion: In conclusion, extensive STAS is an independent factor of poor prognosis in LUSC. STAS is correlated with the presence of other poor prognostic factors such as emboli and pleural invasion and would reflect greater tumor aggressiveness.

Indexed as

prognosticSpread Through Air Spacessquamous cell carcinomatumor grading

Identifiers

PMID35565410
PMCPMC9101151
OpenAlexW4225329186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.